FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

23403811000001104: Xarelto 15mg tablets (Bayer Plc) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Nov 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
76688401000001111 Xarelto 15mg tablets (Bayer Plc) 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
76688501000001110 Xarelto 15mg tablets (Bayer Plc) 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Is a Rivaroxaban 15mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has AMP Xarelto 15mg tablets (Bayer Plc) true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has specific active ingredient Rivaroxaban true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start